½ÃÀ庸°í¼­
»óǰÄÚµå
1525276

¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç° ¹× ¼­ºñ½º, ¼Ò½º À¯Çü, ¿ëµµ, ¾ç½Ä, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Intraoperative Neuromonitoring market Size study, by Products and Services, by Source Type, by Application, by Modality, by End User and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀåÀº 2023³â ¾à 50¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 6.1% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM)Àº ¼ö¼ú Áß ½Å°æ °æ·Î¿¡ ´ëÇÑ ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÏ¿© ¼ö¼ú Áß ½Å°æ°èÀÇ ¹«°á¼ºÀ» º¸ÀåÇÏ´Â Áß¿äÇÑ ÀÇ·á ±â¼úÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº Àü±Ø, ¼¾¼­ µî ´Ù¾çÇÑ Ã·´Ü ±â¼úÀ» »ç¿ëÇÏ¿© ½Å°æ Ȱµ¿À» ¸ð´ÏÅ͸µÇÏ¿© ¼ö¼úÀÇ Á¤È®¼º°ú ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÔ´Ï´Ù. ³ë·É Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü Áúȯ, ¾Ï, °ñ°üÀý¿° µî Áúº´ÀÇ È®»êÀº IONM ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó À̵é ÁúȯÀÇ ¹ß»ý·üµµ ±ÞÁõÇϰí ÀÖ¾î Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á¹ýÀÌ ÇÊ¿äÇϸç, ÀÌ ¶§ IONMÀÌ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü±Ø °³¼±, ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®, °í±Þ ½ÅÈ£ ó¸® µî IONM ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº ÀÌ·¯ÇÑ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº IONMÀÇ ±â´ÉÀ» ´õ¿í °­È­ÇÏ¿© Çö´ë ¿Ü°ú Áø·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº µµÀÔ ºñ¿ë, Á¦ÇÑµÈ »óȯ Á¤Ã¥, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·Àº ½ÃÀå ¼ºÀå¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, IONMÀÇ Á¢±Ù¼º°ú °æÁ¦¼ºÀ» ³ôÀ̱â À§Çؼ­´Â ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¼¼°è °æ±â ħüÀÇ ¿µÇâµµ ½ÃÀå¿¡ ÀÌÁßÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °æÁ¦Àû Á¦¾àÀ¸·Î ÀÎÇØ ÀÇ·á ¿¹»êÀÌ Á¦ÇѵǾî Ä¡·á Ƚ¼ö°¡ °¨¼ÒÇÏ´Â ¹Ý¸é, ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿¹¹æÀû ÀÌÁ¡ÀÌ ÀÖ´Â IONMÀÇ Ã¤ÅÃÀÌ ÃËÁøµÇ°í ÃßÀû Ä¡·áÀÇ Çʿ伺ÀÌ °¨¼ÒÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â ±â¼ú ¹ßÀü°ú Àü·«Àû Æ÷Áö¼Å´×ÀÌ Áß¿äÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀåÀ» Á¶»çÇÑ ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀÌ ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â 2023³â ½ÃÀåÀ» Àå¾ÇÇÏ°í ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ¸¸¼º Áúȯ ¹ß»ý·ü·Î ÀÎÇØ ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÷´Ü IONM ±â¼ú äÅðú ¸¸¼º ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ÅõÀÚ¿Í ÁÖ¿ä »ê¾÷ ±â¾÷ÀÇ Á¸Àç´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð£¦¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½ºº°
    • ¼Ò½º À¯Çüº°
    • ¿ëµµº°
    • ¸ð´Þ¸®Æ¼º°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦2Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼ú Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç° ¹× ¼­ºñ½ºº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • ½Ã½ºÅÛ
    • ºÎ¼Óǰ
    • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¼Ò½º À¯Çüº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : ¼Ò½º À¯Çüº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • Àμҽº ¸ð´ÏÅ͸µ
    • ¾Æ¿ô¼Ò½Ì ¸ð´ÏÅ͸µ

Á¦7Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð ¿¹Ãø : ¿ëµµº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : ¿ëµµº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • ôÃ߿ܰú ¼ö¼ú
    • ³ú½Å°æ¿Ü°ú ¼ö¼ú
    • Á¤Çü¿Ü°ú ¼ö¼ú
    • À̺ñÀÎÈİú ¼ö¼ú
    • Ç÷°ü¿Ü°ú ¼ö¼ú
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¸ð´Þ¸®Æ¼º°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : ¸ð´Þ¸®Æ¼º° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • ¿îµ¿ À¯¹ß ÀüÀ§(MEP)
    • üÁú °¨°¢ À¯¹ß ÀüÀ§(SSEP)
    • ³úÆÄ(EEG)
    • ±ÙÀüµµ(EMG)
    • ³úÀÇ ÁßÃߺΠû°¢ À¯¹ß ÀüÀ§(BAEP)
    • ½Ã°¢ À¯¹ß ÀüÀ§(VEP)

Á¦9Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº° : 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • º´¿ø
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)

Á¦10Àå ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • NuVasive, Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Computational Diagnostics, Inc.
    • inomed Medizintechnik GmbH
    • NeuroStyle Pte. Ltd.
    • Intranerve Neuroscience Holdings, LLC
    • Accurate Monitoring
    • Natus Medical Incorporated
    • SpecialtyCare
    • Nihon Kohden Corporation
    • Medtronic plc

Á¦12Àå Á¶»ç °úÁ¤

LSH 24.08.20

Global Intraoperative Neuromonitoring market is valued approximately at USD 5.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2024-2032. Intraoperative Neuromonitoring (IONM) is a crucial medical technique that ensures the integrity of the nervous system during surgical procedures by providing real-time feedback on neural pathways. This method employs various advanced technologies, including electrodes and sensors, to monitor neural activity, enhancing surgical precision and patient safety. The increasing geriatric population, along with the prevalence of diseases such as cardiovascular conditions, cancer, and osteoarthritis, significantly propels the demand for IONM. As the aging population grows, the incidence of these diseases is correspondingly soaring, which, in turn, necessitating accurate diagnostic and treatment methods where IONM plays a pivotal role.

Continuous advancements in IONM technologies, such as improved electrodes, real-time data analysis, and advanced signal processing, drive market growth by enhancing the precision and reliability of these monitoring systems. The integration of artificial intelligence and machine learning further augments the capabilities of IONM, making it indispensable in modern surgical practices. However, the high costs of implementation, limited reimbursement policies, and a shortage of skilled professionals pose significant challenges to market growth. Addressing these issues is essential to enhance accessibility and affordability of IONM. The impact of a global recession also presents a dual effect on the market. While economic constraints can limit healthcare budgets and reduce procedural volumes, the emphasis on cost-effective healthcare solutions can drive the adoption of IONM due to its preventive benefits, reducing the need for follow-up treatments. Technological advancements and strategic positioning will be crucial in overcoming these economic challenges.

The key regions considered for the global Intraoperative Neuromonitoring Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2023 and is expected to maintain its lead due to its advanced medical infrastructure and high incidence of chronic conditions. Meanwhile, Asia-Pacific is anticipated to exhibit the fastest growth during the forecast period, driven by the adoption of advanced IONM technologies and the prevalence of chronic diseases in the region. Furthermore, significant investments and the presence of key industry players are accelerating the growth of the intraoperative neuromonitoring market in Asia-Pacific.

Major market players included in this report are:

  • SpecialtyCare
  • Nihon Kohden Corporation
  • NuVasive, Inc.
  • Computational Diagnostics, Inc.
  • inomed Medizintechnik GmbH
  • NeuroStyle Pte. Ltd.
  • Intranerve Neuroscience Holdings, LLC
  • Accurate Monitoring
  • Medtronic plc
  • Natus Medical Incorporated

The detailed segments and sub-segment of the market are explained below:

By Products and Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • ENT Surgery
  • Vascular Surgery
  • Other surgeries

By Modality

  • Motor evoked potentials (MEPs)
  • Somatosensory evoked potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem auditory evoked potentials (BAEPs)
  • Visual evoked potentials (VEPs)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Intraoperative Neuromonitoring market Executive Summary

  • 1.1. Global Intraoperative Neuromonitoring market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Products and Services
    • 1.3.2. By Source Type
    • 1.3.3. By Application
    • 1.3.4. By Modality
    • 1.3.5. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Intraoperative Neuromonitoring market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Intraoperative Neuromonitoring market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing Geriatric Population
    • 3.1.2. Technological Advancements
    • 3.1.3. Rising Prevalence of Target Diseases
  • 3.2. Market Challenges
    • 3.2.1. High Implementation Costs
    • 3.2.2. Limited Reimbursement Policies
    • 3.2.3. Shortage of Skilled Professionals
  • 3.3. Market Opportunities
    • 3.3.1. Integration of AI and Machine Learning
    • 3.3.2. Growing Focus on Remote Patient Monitoring
    • 3.3.3. Expansion in Emerging Markets

Chapter 4. Global Intraoperative Neuromonitoring market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Intraoperative Neuromonitoring market Size & Forecasts by Products and Services 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Intraoperative Neuromonitoring market: Products and Services Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Systems
    • 5.2.2. Accessories
    • 5.2.3. Services

Chapter 6. Global Intraoperative Neuromonitoring market Size & Forecasts by Source Type 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Intraoperative Neuromonitoring market: Source Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Insourced Monitoring
    • 6.2.2. Outsourced Monitoring

Chapter 7. Global Intraoperative Neuromonitoring market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Intraoperative Neuromonitoring market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Spinal Surgery
    • 7.2.2. Neurosurgery
    • 7.2.3. Orthopedic Surgery
    • 7.2.4. ENT Surgery
    • 7.2.5. Vascular Surgery
    • 7.2.6. Other surgeries

Chapter 8. Global Intraoperative Neuromonitoring market Size & Forecasts by Modality 2022-2032

  • 8.1. Segment Dashboard
  • 8.2. Global Intraoperative Neuromonitoring market: Modality Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 8.2.1. Motor evoked potentials (MEPs)
    • 8.2.2. Somatosensory evoked potentials (SSEPs)
    • 8.2.3. Electroencephalography (EEG)
    • 8.2.4. Electromyography (EMG)
    • 8.2.5. Brainstem auditory evoked potentials (BAEPs)
    • 8.2.6. Visual evoked potentials (VEPs)

Chapter 9. Global Intraoperative Neuromonitoring market Size & Forecasts by End User 2022-2032

  • 9.1. Segment Dashboard
  • 9.2. Global Intraoperative Neuromonitoring market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 9.2.1. Hospitals
    • 9.2.2. Ambulatory Surgical Centers (ASCs)

Chapter 10. Global Intraoperative Neuromonitoring market Size & Forecasts by Region 2022-2032

  • 10.1. North America Intraoperative Neuromonitoring market
    • 10.1.1. U.S. Intraoperative Neuromonitoring market
      • 10.1.1.1. Products and Services breakdown size & forecasts, 2022-2032
      • 10.1.1.2. Source Type breakdown size & forecasts, 2022-2032
      • 10.1.1.3. Application breakdown size & forecasts, 2022-2032
      • 10.1.1.4. Modality breakdown size & forecasts, 2022-2032
      • 10.1.1.5. End User breakdown size & forecasts, 2022-2032
    • 10.1.2. Canada Intraoperative Neuromonitoring market
  • 10.2. Europe Intraoperative Neuromonitoring market
    • 10.2.1. U.K. Intraoperative Neuromonitoring market
    • 10.2.2. Germany Intraoperative Neuromonitoring market
    • 10.2.3. France Intraoperative Neuromonitoring market
    • 10.2.4. Spain Intraoperative Neuromonitoring market
    • 10.2.5. Italy Intraoperative Neuromonitoring market
    • 10.2.6. Rest of Europe Intraoperative Neuromonitoring market
  • 10.3. Asia-Pacific Intraoperative Neuromonitoring market
    • 10.3.1. China Intraoperative Neuromonitoring market
    • 10.3.2. India Intraoperative Neuromonitoring market
    • 10.3.3. Japan Intraoperative Neuromonitoring market
    • 10.3.4. Australia Intraoperative Neuromonitoring market
    • 10.3.5. South Korea Intraoperative Neuromonitoring market
    • 10.3.6. Rest of Asia Pacific Intraoperative Neuromonitoring market
  • 10.4. Latin America Intraoperative Neuromonitoring market
    • 10.4.1. Brazil Intraoperative Neuromonitoring market
    • 10.4.2. Mexico Intraoperative Neuromonitoring market
    • 10.4.3. Rest of Latin America Intraoperative Neuromonitoring market
  • 10.5. Middle East & Africa Intraoperative Neuromonitoring market
    • 10.5.1. Saudi Arabia Intraoperative Neuromonitoring market
    • 10.5.2. South Africa Intraoperative Neuromonitoring market
    • 10.5.3. Rest of Middle East & Africa Intraoperative Neuromonitoring market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. NuVasive, Inc.
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Market Strategies
    • 11.3.2. Computational Diagnostics, Inc.
    • 11.3.3. inomed Medizintechnik GmbH
    • 11.3.4. NeuroStyle Pte. Ltd.
    • 11.3.5. Intranerve Neuroscience Holdings, LLC
    • 11.3.6. Accurate Monitoring
    • 11.3.7. Natus Medical Incorporated
    • 11.3.8. SpecialtyCare
    • 11.3.9. Nihon Kohden Corporation
    • 11.3.10. Medtronic plc

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦